Wafik El-Deiry earns international award for cancer disease work

January 12, 2011

Wafik. S. El-Diery, Rose Dunlap professor and chair, hematology/oncology, Penn State College of Medicine, and associate director for translational research at Penn State Hershey Cancer Institute, was awarded the Kuwait Prize in Applied Sciences. The international award is thought of as the equivalent of the Nobel Prize in the Middle East. He received the award for his distinguished accomplishments in cancerous disease research, including work on tumor suppressor genes p53 and TRAIL, mechanisms that determine cancer therapeutic response, and new strategies targeting cell death for cancer therapy.

The prize was awarded to El-Diery by the Kuwait Foundation for the Advancement of Sciences (KFAS).

KFAS prizes recognize intellectual achievements that serve the interest of scientific advancement and support efforts to raise the standard of culture in various fields. The prize is administered by the KFAS under the management of the Amir of Kuwait, His Highness The Amir Sheikh Sabah Al-Ahmed Al-Jaber Al-Sabah, who presides over its board of directors, and the director general of the foundation, Ali Al-Shamlan.

El-Deiry also is an American Cancer Society Research Professor, a highly cited author with nearly 300 peer-reviewed original manuscripts and reviews, and has edited four books. He is a member of numerous professional societies including the Association of American Physicians, the American Society for Clinical Investigation, the Interurban Clinical Club, the American Association for Cancer Research and the American Society of Clinical Oncology. He has been cited as one of “America’s Top Oncologists” by the Consumers’ Research Council of America. He serves as editor-in-chief of Cancer Biology and Therapy.

  • IMAGE: Penn State

(Media Contacts)

Last Updated March 21, 2011